SCHEMBL257668

SCHEMBL257668

COCCc1cc(C(=O)c2ccccc2F)ccc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 1/20 0.46
CDC25B P30305 1/20 0.46
HSD17B10 Q99714 1/20 0.46
POLB P06746 3/20 0.44
KMT2A Q03164 2/20 0.44
PYGL P06737 1/20 0.43
LMNA P02545 1/20 0.42
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 1/20 0.41
GAA P10253 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 2/20 0.40
ABCC9 O60706 1/20 0.39
ABCC8 Q09428 1/20 0.39
KCNJ11 Q14654 1/20 0.39
KCNJ8 Q15842 1/20 0.39
SRD5A2 P31213 1/20 0.39
MAPK1 P28482 1/20 0.39
MAPK14 Q16539 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL257672 0.89 ALDH1A1 (0.47) POLBKMT2APYGLLMNAALDH1A1
SCHEMBL15197152 0.86 KMT2A (0.45) POLBKMT2AALDH1A1KDM4EGAA
SCHEMBL15100954 0.80 CDC25A (0.48) CDC25ACDC25BHSD17B10POLBKMT2A
SCHEMBL15197150 0.78 CYP4F2 (0.43) POLBKMT2AALDH1A1GAAL3MBTL1
SCHEMBL257674 0.77 ALDH1A1 (0.64) CDC25ACDC25BHSD17B10POLBKMT2A
SCHEMBL8962320 0.76 CDC25B (0.77) CDC25ACDC25BHSD17B10POLBKMT2A
SCHEMBL8245934 0.76 FOLH1 (0.59) HSD17B10LMNAALDH1A1KDM4EHPGD
SCHEMBL257257 0.75 LMNA (0.54) CDC25ACDC25BHSD17B10POLBKMT2A
SCHEMBL11685106 0.74 AKR1C3 (0.51) KMT2AALDH1A1KDM4EHPGDTSHR
SCHEMBL8074156 0.74 KMT2A (0.46) CDC25ACDC25BHSD17B10POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895552-B2 Cyclic amide derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2014-11-25 US disclosed
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2013-08-22 US disclosed
EP-2612848-A1 CYCLIC AMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2013-07-10 EP disclosed
WO-2012029942-A1 CYCLIC AMIDE DERIVATIVE 大日本住友製薬株式会社 (JP) 2012-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130217692-A1 CYCLIC AMIDE DERIVATIVE HDAC10, H1-10, H1-0 CDC25A 728/4885CDC25B 497/4885HSD17B10 146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.